The Patent Finder

Crimagua Limited

Also on record
Records under this name other than patents Crimagua Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Crimagua Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 7,625,560Humanized Antibodies That Recognize Beta Amyloid Peptide
conveyed to Janssen Alzheimer Immunotherapy, Wyeth - now held by Wyeth LLC
In force
 · High confidence
In forceHigh confidence
US 7,635,473Anti a Beta Antibody Formulation
conveyed to Janssen Alzheimer Immunotherapy, Wyeth - now held by Wyeth LLC
In force
 · High confidence
In forceHigh confidence
US 9,644,025Immunotherapy Regimes Dependent on Apoe Status
conveyed to Janssen Alzheimer Immunotherapy, Wyeth - now held by Janssen Sciences Ireland Uc
In force
 · High confidence
In forceHigh confidence
US 8,357,781Neuroactive Fragments of App
Lapsed on the fee record
Ended Jan 22, 2025 · High confidence
Lapsed on the fee recordEnded Jan 22, 2025High confidence
US 7,871,615Humanized Antibodies That Recognize Beta Amyloid Peptide
conveyed to Janssen Alzheimer Immunotherapy, Wyeth - now held by Wyeth LLC
Term ended
Term ended Jun 19, 2024 · High confidence
Term endedTerm ended Jun 19, 2024High confidence
US 9,051,363Humanized Antibodies That Recognize Beta Amyloid Peptide
conveyed to Janssen Alzheimer Immunotherapy, Wyeth - now held by Janssen Sciences Ireland Uc
Term ended
Term ended Jan 1, 2022 · Low confidence
Term endedTerm ended Jan 1, 2022Low confidence
US 8,613,920Treatment of Amyloidogenic Diseases
conveyed to Janssen Alzheimer Immunotherapy, Wyeth - now held by Janssen Sciences Ireland Uc
Lapsed on the fee record
Ended Dec 24, 2021 · High confidence
Lapsed on the fee recordEnded Dec 24, 2021High confidence
US 8,318,164Anti a Beta Antibody Formulation
conveyed to Janssen Alzheimer Immunotherapy, Wyeth - now held by Wyeth LLC
Lapsed on the fee record
Ended Nov 27, 2020 · High confidence
Lapsed on the fee recordEnded Nov 27, 2020High confidence
US 7,790,856Humanized Antibodies That Recognize Beta Amyloid Peptide
conveyed to Janssen Alzheimer Immunotherapy, Wyeth - now held by Janssen Alzheimer Immunotherapy
Term ended
Ended no later than Nov 10, 2020 · Low confidence
Term endedEnded no later than Nov 10, 2020Low confidence
US 8,227,403A-Beta Immunogenic Peptide Carrier Conjugates and Methods of Producing Same
conveyed to Janssen Alzheimer Immunotherapy, Wyeth - now held by Janssen Sciences Ireland Uc
Lapsed on the fee record
Ended Jul 24, 2020 · Medium confidence
Lapsed on the fee recordEnded Jul 24, 2020Medium confidence
10 of 43 records shown.
Pro members see all 43.
Pro members: see all 43 records
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited